This Rakesh Jhunjhunwala-backed stock jumps 5%; analysts see more upside

/2 min read

ADVERTISEMENT

Analysts at Motilal Oswal have initiated a ‘buy’ coverage on the stock with a target price of ₹750 per share amid earnings optimism and improvement in the overall health insurance industry.
This Rakesh Jhunjhunwala-backed stock jumps 5%; analysts see more upside
Star Health shares jumped nearly 5% in intraday on Monday.  Credits: Getty Images

Shares of health insurance firm Star Health and Allied Insurance Company surged nearly 5% in opening trade on Monday after brokerage firm Motilal Oswal initiated a ‘buy’ coverage on the stock. The shares extended rally for the second straight session after the company received a buy call from the brokerage house at a target price of ₹750 per share, an upside of 17.6% from the last closing price of ₹637.60 apiece on the BSE. The stock has fallen nearly 30% since its listing on the domestic exchange on December 10, 2021.

Ace investor Rakesh Jhunjhunwala and his wife Rekha Jhunjhunwala together own a 17.51% equity stake in the company, as per the latest shareholding pattern available on the BSE. Jhunjhunwala is the second-biggest promoter of the company after Safecrop Investments India LLP, which holds 41.19% shares in the insurance firm.

fortune magazine cover
Fortune India Latest Edition is Out Now!
The Year Of EV Launches

September 2025

2025 is shaping up to be the year of electric car sales. In a first, India’s electric vehicles (EV) industry crossed the sales milestone of 100,000 units in FY25, fuelled by a slew of launches by major players, including Tata Motors, M&M, Ashok Leyland, JSW MG Motor, Hyundai, BMW, and Mercedes-Benz. The issue also looks at the challenges ahead for Tata Sons chairman N. Chandrasekaran in his third term, and India’s possible responses to U.S. president Donald Trump’s 50% tariff on Indian goods. Read these compelling stories in the latest issue of Fortune India.

Read Now

The stock received a buy call, citing improvement in the earnings going ahead and improvement in the overall health insurance industry. Star Health, the market leader in the Indian health insurance industry with a retail market share of 31%, is poised to grow at a relatively faster pace vis-à-vis the overall health insurance industry,” Motilal Oswal said in its initiation note.

The brokerage expects Star Health to report a gross premium compound annual growth rate (CAGR) of 25% over FY21-24E, from a loss of ₹830 crore in FY21 to a net profit of ₹1,080 crore in FY24.

Meanwhile, research firm Crisil has forecasted that the health insurance industry is expected to see a CAGR of 18%, 23%, 15% and 11% in the total, retail, group and government segments, respectively, over FY21–25. Analysts at Emkay Global pegged a 20% rise in the niche market over a 10-year period and expect Star Health to further boost its presence in the nascent market.

On Monday, Star Health shares opened at day’s high of ₹668.80, up 4.9% against Thursday’s closing price of ₹637.60 on the BSE. The stock trades marginally higher than its 52-week low of ₹603 touched on March 16, 2022. It hit a 52-week high of ₹940 on its listing day on December 10, 2021. The market capitalisation of the company today stood at ₹37,564 crore.

Star Health and Allied Insurance, owned by a consortium of investors including Rakesh Jhunjhunwala and Westbridge Capital, raised ₹6,400 crore in its initial public offering (IPO) at a price range of ₹870-900 apiece. Formed in 2006, the private health insurer captures 15.8% of the market share, while it holds 31% in the retail health segment.

In the December quarter of 2021, the health insurance major posted a net loss of ₹578.37 crore, compared to a loss of ₹241.90 crore in the year-ago period. However, its sales soared 78.1% YoY to ₹2,528.3 crore in Q3 FY22.

Fortune India is now on WhatsApp! Get the latest updates from the world of business and economy delivered straight to your phone. Subscribe now.